Aligos Therapeutics, Inc. · NASDAQ:ALGS
EcoR1 Capital, LLC's stake in Aligos Therapeutics, Inc. fell to 3.90% (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
EcoR1 Capital, LLC's stake in Aligos Therapeutics, Inc. fell to 3.90%, 210,634 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 3.90%
- Shares
- 210,634
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| EcoR1 Capital, LLC | 3.90% | 210,634 |
| Oleg Nodelman | 3.90% | 210,634 |
| EcoR1 Capital Fund Qualified, L.P. | 3.70% | 199,036 |
Source
Related
- Aligos Therapeutics, Inc.
- EcoR1 Capital, LLC
- Aligos Therapeutics, Inc. shareholders
- Schedule 13D · Lawrence M. Blatt · Jun 24, 2026
- Schedule 13G/A · Woodline Partners LP · May 15, 2026
- Schedule 13G · Lawrence M. Blatt · May 15, 2026
- Schedule 13G/A · Woodline Partners LP · Feb 17, 2026
- Schedule 13G/A · Sio Capital Management, LLC · Feb 11, 2026